The resignation of one of the FDA's top officials, Peter Marks, is worrying Wall Street as they await a replacement.
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed ...